Latest Regulatory News

CSL Limited posted a 14% rise in net profit for FY2025, underpinned by strong immunoglobulin sales and new product launches, while announcing plans to demerge its vaccines business, CSL Seqirus, to sharpen strategic focus.

Kaili Resources addresses ASX price query following a dramatic surge in its share price and trading volume, attributing the movement to its recent rare earth element drilling approval in South Australia.

Platinum Asia Investments Limited (PAI) shares have been suspended following Federal Court approval of a scheme exchanging all shares for units in the Platinum Asia Fund Complex ETF (PAXX). This marks a significant structural shift for PAI investors.

The Takeovers Panel has declined to intervene in the ongoing takeover tussle for PointsBet Holdings, allowing shareholders to weigh competing offers from MIXI Australia and betr Entertainment.

MAC Copper has secured Foreign Investment Review Board approval, satisfying all regulatory conditions for its acquisition by Harmony Gold’s Australian subsidiary. The deal now awaits shareholder votes and court sanction to proceed.

Peak Rare Earths Limited has entered a scheme of arrangement with Shenghe Resources (Singapore) Pte. Ltd., valuing the company at approximately A$158 million. The scheme offers Peak shareholders a cash consideration of no less than A$0.359 per share, representing a 199% premium to the last closing price.

ClearVue Technologies has responded to ASX concerns after its CEO described previous project pipeline announcements as ‘fairy tales,’ affirming prior disclosures were accurate despite some project setbacks.

betr Entertainment has withdrawn its Notice of Meeting and cancelled the Selective Buy-Back Meeting following an undertaking with the Takeovers Panel related to its takeover offer for PointsBet. A new combined shareholder meeting will be called soon.

Lake Resources has tapped its At-the-Market facility to raise A$1.575 million, aiming to fund key development stages of its flagship Kachi lithium project in Argentina.

Kaili Resources has addressed a sharp spike in its share price and trading volume, attributing the market interest to its recent approval for rare earth element drilling in South Australia, while confirming no undisclosed material information.

McLaren Minerals reports promising early Phase 1 drilling results at its McLaren Titanium Project, revealing high-grade heavy mineral assays beyond current resource boundaries and signaling strong potential for resource expansion.

Rhythm Biosciences has launched a $3.75 million placement alongside an offer of over 52 million new options, all contingent on shareholder approval. The move aims to bolster working capital as the company advances its cancer diagnostic products.